期刊文献+

鼻咽癌组织中PI3K、mTOR的表达及临床意义 被引量:4

Expression and significance of PI3K and mTOR in nasopharyngeal carcinoma
下载PDF
导出
摘要 目的研究鼻咽癌组织中磷脂酰肌醇3-激酶(phosphoinositide 3-kinase,PI3K)、哺乳动物雷帕霉素靶蛋白(mammalian target of rapamycin,mTOR)的表达及其临床意义。方法采用免疫组化方法检测PI3K、mTOR在47例鼻咽癌和20例鼻息肉组织中的表达,回顾性研究表达与TNM分期、浸润、转移的关系。结果①鼻咽癌组及鼻息肉组中PI3K的阳性表达率分别为76.6%(36/47)、35.0%(7/20),mTOR分别为70.2%(33/47)、25.0%(5/20),差异均有统计学意义(χ2=12.36,χ2=11.6,P均<0.05);②鼻咽癌组织中,角化型鳞状细胞癌组与非角化型鳞状细胞癌组PI3K的阳性表达率分别为65.0%、85.1%,差异无统计学意义(χ2=2.61,P>0.05),mTOR分别为55.0%、81.5%,差异有统计学意义(χ2=3.85,P<0.05),I期+II期、III期+IV期组中PI3K的阳性表达率分别为80.0%、72.7%,mTOR为72.0%、68.2%,差异均无统计学意义(χ2=0.35,χ2=0.08,P均>0.05)。有无淋巴结转移组中PI3K的阳性表达率分别为70.0%、88.2%,mTOR为76.7%、58.8%,差异均无统计学意义(χ2=2.91,χ2=1.65,P均>0.05)。结论 PI3K及mTOR在鼻咽癌发生发展中起一定作用,mTOR与鼻咽癌的病理分型有相关性。 OBJECTIVE To investigate the expression and significance of PI3K(phosphoinositide 3-kinase)and mTOR(mammalian target of rapamycin) in nasopharyngeal carcinoma(NPC).METHODS Immunohistochemical Envision method was used to detect the expression of PI3K and mTOR in 47 specimen of nasopharyngeal carcinoma and 20 specimen of nasal polyp.The results were analyzed with the clinicopathological characteristics of NPC patients.RESULTS ①Positive expression rate of PI3K in NPC group and nasal polyp group was 76.6%(36/47) and 35.0%(7/20)respectively,mTOR was 70.2%(33/47)and 25.0%(5/20)respectively.There was a statistically difference between two groups(P 0.05).②In NPC tissues,positive expression rate of PI3K in groups of keratinizing squamous cell carcinoma and nonkeratinizing carcinoma was 65.0% and 85.1% respectively,and the expression difference showed no statistical significance(χ 2 =2.61,P0.05),and that of mTOR was 55.0% and 81.5% respectively,the expression difference was of statistical significance(χ 2 =3.85,P 0.05).Positive expression rates of PI3K and mTOR were 80.0% vs 72.7% and 72.0% vs 68.2% in early and advanced group respectively,and there were no statistic significance(χ 2 =0.35,χ 2 =0.08,all P0.05).Positive expression rates of PI3K and mTOR in NPC tissues with or without lymphatic metastasis were 70% vs 88.2% and 76.7% vs 58.8% respectively,and there were no statistic significance(χ 2 =2.91,χ 2 =1.65,all P0.05).CONCLUSION The results suggested that PI3K and mTOR may play an important role in the occurrence and development of NPC.mTOR has a relationship with the pathological types of NPC.
作者 韩艳艳 李芳
出处 《中国耳鼻咽喉头颈外科》 2012年第5期252-254,共3页 Chinese Archives of Otolaryngology-Head and Neck Surgery
关键词 鼻咽肿瘤 1-磷脂酰肌醇3-激酶 西罗莫司 预后 Nasopharyngeal Neoplasms 1-Phosphatidylinositol 3-Kinase Sirolimus Prognosis
  • 相关文献

参考文献11

二级参考文献49

  • 1张大勇,黄中新.Sonic hedgehog信号通路在肺发育及肺癌发生中的意义[J].解剖学研究,2007,29(1):68-72. 被引量:1
  • 2温星桥,李小娟,罗云,王林,周祥福,蔡育彬,温机灵,高新.生育酚结合蛋白通过磷酸肌醇3激酶途径抑制前列腺癌的生长[J].中山大学学报(医学科学版),2007,28(4):367-372. 被引量:4
  • 3Shamji AF, Nghiem P, Schreiber SI,. Integration of growth factor anti nutrient signaling: implications for cancer biology [ J ]. Mol Cell, 2003,12 (2) : 271-280.
  • 4Ayanta D, Stephanie JW, Joan SB. Akt activation disrupts mammary aeinar architecture and enhances proliferation in an mTOR-dependent manner [ J]. J Cell Biol, 2003,163(2) :315-326.
  • 5Lin H J, Hsieh FC, Song H, et al. Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer [J]. Br J Cancer, 2005,93 (12) : 1372-1381.
  • 6Tsurutani J, West KA, Sayyah J, et al. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinih mesylate or chemotherapy [J]. Cancer Res, 2005,65 (18) :8423- 8432.
  • 7Takeuchi H, Kondo Y, Fujiwara K, et al. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/ protein kinase B inhibitors [J]. Cancer Res, 2005,65 (8) :3336-3346.
  • 8Keith CT, Schreiber SL. PIK-related kinases: DNA repair, recombination, and cell cycle checkpoint [J]. Science, 1995,270(5233) :50-51.
  • 9Bjornsti MA, Houghton PJ. The TOR pathway: a target for cancer therapy [J]. Nat rev Cancer, 2004,4(5): 335-348.
  • 10Emanuel FP, Virginia E, Robyn PA, et al. Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival [J]. Cancer Res, 2007,67(7) :3431-3440.

共引文献49

同被引文献31

  • 1范德生,李泽民,孙宁.姜黄素对人鼻咽癌CNE-2Z细胞侵袭和转移的体外实验研究[J].中国癌症杂志,2011,21(6):452-456. 被引量:6
  • 2梁统,陈美珺,周克元,唐旭东,王旭光.姜黄素诱导低分化鼻咽癌细胞株CNE-2Z的凋亡[J].癌症,2004,23(12):1651-1654. 被引量:13
  • 3姚运红,余健华,熊晖.姜黄素体内外对鼻咽癌的抗癌作用[J].肿瘤防治研究,2006,33(7):487-489. 被引量:8
  • 4Colaco RJ,Betts G,Donne A,et al.Nasopharyngeal carcinoma:a retrospective review of demographics,treatment and patient outcome in a single centre[J].Clin Oncol(R Coll Radiol),2013,25(3):171-177.
  • 5Liu H,Chen QY,Guo L,et al.Feasibility and efficacy of chemoradiotherapy for elderly patients with locoregionally advanced nasopharyngeal carcinoma:results from a matched cohort analysis[J].Radiat Oncol,2013,8(1):70.
  • 6Li F,Song D,Lu Y,et al.Delayed-type hypersensitivity(DTH)immune response related with EBV-DNA in nasopharyngeal carcinoma treated with autologous dendritic cell vaccination after radiotherapy[J].J Immunother,2013,36(3):208-214.
  • 7Smith ME,Bauer-Wu S.Traditional Chinese Medicine for cancer-related symptoms[J].Semin Oncol Nurs,2012,28(1):64-74.
  • 8Song MF,Li YS,Ootsuyama Y,et al.Urea,the most abundant component in urine,cross-reacts with a commercial 8-OH-dG ELISA kit and contributes to overestimation of urinary 8-OH-dG[J].Free Radic Biol Med,2009,47(1):41-46.
  • 9Memmott RM,Dennis PA.Akt-dependent and-independent mechanisms of mTOR regulation in cancer[J].Cell Signal,2009,21(5):656-664.
  • 10Fresno Vara JA,Casado E,De Castro J,et al.PI3K/Akt signalling pathway and cancer[J].Cancer Treat Rev,2004,30(2):193-204.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部